rs4426144

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001378964.1(CDON):​c.640+12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0929 in 1,611,886 control chromosomes in the GnomAD database, including 7,341 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 856 hom., cov: 32)
Exomes 𝑓: 0.092 ( 6485 hom. )

Consequence

CDON
NM_001378964.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.488

Publications

5 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
CDON Gene-Disease associations (from GenCC):
  • holoprosencephaly 11
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 11-126018318-C-T is Benign according to our data. Variant chr11-126018318-C-T is described in ClinVar as Benign. ClinVar VariationId is 260803.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.640+12G>A intron_variant Intron 5 of 19 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.640+12G>A intron_variant Intron 5 of 19 1 NM_001378964.1 ENSP00000432901.2 Q4KMG0-2E9PN78

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15783
AN:
152048
Hom.:
853
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.0983
Gnomad EAS
AF:
0.121
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.127
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0878
Gnomad OTH
AF:
0.100
GnomAD2 exomes
AF:
0.109
AC:
27290
AN:
250998
AF XY:
0.107
show subpopulations
Gnomad AFR exome
AF:
0.119
Gnomad AMR exome
AF:
0.145
Gnomad ASJ exome
AF:
0.103
Gnomad EAS exome
AF:
0.136
Gnomad FIN exome
AF:
0.128
Gnomad NFE exome
AF:
0.0859
Gnomad OTH exome
AF:
0.0993
GnomAD4 exome
AF:
0.0918
AC:
133977
AN:
1459720
Hom.:
6485
Cov.:
31
AF XY:
0.0921
AC XY:
66886
AN XY:
726286
show subpopulations
African (AFR)
AF:
0.112
AC:
3735
AN:
33434
American (AMR)
AF:
0.141
AC:
6303
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
2688
AN:
26112
East Asian (EAS)
AF:
0.123
AC:
4877
AN:
39660
South Asian (SAS)
AF:
0.116
AC:
10013
AN:
86208
European-Finnish (FIN)
AF:
0.125
AC:
6685
AN:
53372
Middle Eastern (MID)
AF:
0.0726
AC:
378
AN:
5206
European-Non Finnish (NFE)
AF:
0.0841
AC:
93430
AN:
1110740
Other (OTH)
AF:
0.0973
AC:
5868
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
5577
11154
16732
22309
27886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3576
7152
10728
14304
17880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15815
AN:
152166
Hom.:
856
Cov.:
32
AF XY:
0.106
AC XY:
7874
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.114
AC:
4731
AN:
41518
American (AMR)
AF:
0.126
AC:
1928
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0983
AC:
341
AN:
3468
East Asian (EAS)
AF:
0.122
AC:
634
AN:
5184
South Asian (SAS)
AF:
0.122
AC:
586
AN:
4814
European-Finnish (FIN)
AF:
0.127
AC:
1345
AN:
10590
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0878
AC:
5969
AN:
67994
Other (OTH)
AF:
0.104
AC:
219
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
740
1479
2219
2958
3698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0931
Hom.:
249
Bravo
AF:
0.102
Asia WGS
AF:
0.162
AC:
562
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 11 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
13
DANN
Benign
0.80
PhyloP100
-0.49
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4426144; hg19: chr11-125888213; COSMIC: COSV54996038; COSMIC: COSV54996038; API